APELLIS

Apellis is a global biopharmaceutical company that develops life-changing therapies. By pioneering targeted C3 therapies, we aim to treat diseases that are driven by excessive activation of the complement cascade, including those within hematology, ophthalmology, and nephrology... Apellis is formed by people who care, are fearless in the face of a challenge, love the work they do, and continually pursue the highest level of scientific integrity. Each of these values guide every decision we make as we strive toward our vision of being known for our compassion, revolutionary science, and contributions to humankind around the world... At Apellis, we combine courageous science and compassion to develop life-changing medicines for some of the most challenging diseases patients face.

Also known as: Apellis Pharmaceuticals, Apellis Pharmaceuticals, Inc.

Primary location: Waltham United States